About AGLE

Aeglea BioTherapeutics, Inc. (AGLE) is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AGLE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
PZI Invesco Zacks Micro Cap ETF 16.7 M 1.67E+07 400 400 0.23% 0.00233 39 K 38780
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.34933E+09 222 222 0.03% 0.0003 1.9 M 1923080
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.5 B 1.95299E+10 3,547 3547 0.0% 0 44 K 44046
IWC iShares Microcap ETF 847.3 M 8.47282E+08 1,434 1434 0.04% 0.0004 312 K 311757
IWM iShares Russell 2000 ETF 40.5 B 4.05202E+10 1,989 1989 0.01% 0.0001 2.7 M 2676540
IWO iShares Russell 2000 Growth ETF 8.8 B 8.79796E+09 1,232 1232 0.01% 0.0001 1.1 M 1116630
IWV iShares Russell 3000 ETF 9.1 B 9.10141E+09 2,929 2929 0.0% 0 57 K 57417
BIB ProShares Ultra Nasdaq Biotechnology 223.8 M 2.2382E+08 239 239 0.01% 0.000113372 53 K 53138
UBIO Proshares UltraPro Nasdaq Biotechnology 28.3 M 2.82606E+07 228 228 0.01% 7.48966E-05 7 K 6587
URTY ProShares UltraPro Russell2000 85.2 M 8.5176E+07 2,005 2005 0.0% 1.66348E-05 5 K 4543
UWM ProShares Ultra Russell2000 181.5 M 1.8146E+08 2,006 2006 0.0% 2.28247E-05 9 K 9268